We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+101.42%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$669M
AUM Growth
+$482M
Cap. Flow
+$394M
Cap. Flow %
58.85%
Top 10 Hldgs %
31.65%
Holding
214
New
153
Increased
2
Reduced
1
Closed
16

Top Buys

Rank Stock Value
1
NKLA
Nikola Corporation Common Stock
NKLA
+$32.1M
2
TMUS icon
T-Mobile US
TMUS
+$29.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$22.7M
4
DKNG icon
DraftKings
DKNG
+$17.3M
5
PCG icon
PG&E
PCG
+$12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$17.7M
3
FEAC.U
Flying Eagle Acquisition Corp. Units, each consisting of one share of Class A common stock and one-f
FEAC.U
+$5.98M
4
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
+$5M
5
ADC icon
Agree Realty
ADC
+$2.17M

Sector Composition

Rank Sector Weight
1 Healthcare 32.46%
2 Consumer Discretionary 19.77%
3 Communication Services 8.34%
4 Technology 8.26%
5 Financials 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDYA icon
101
IDEAYA Biosciences
IDYA
$3.57B
$1.99M 0.3%
+140,000
New +$1.1M
KIDS icon
102
OrthoPediatrics
KIDS
$607M
$1.97M 0.29%
+45,000
New +$2.02M
RP
103
DELISTED
RealPage, Inc.
RP
$1.95M 0.29%
+30,000
New +$1.89M
RPTX
104
DELISTED
Repare Therapeutics
RPTX
$1.86M 0.28%
+60,000
New +$1.93M
JSPR icon
105
Jasper Therapeutics
JSPR
$25.8M
$1.79M 0.27%
17,500
– –
CHEF icon
106
Chefs' Warehouse
CHEF
$4.5B
$1.76M 0.26%
+130,000
New +$1.79M
AMTI
107
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$1.76M 0.26%
+70,000
New +$1.77M
YARW
108
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
$1.74M 0.26%
+279
New +$1.89M
PLMR icon
109
Palomar
PLMR
$3.46B
$1.72M 0.26%
+20,000
New +$1.33M
VISN
110
Vistance Networks Inc
VISN
$2.54B
$1.67M 0.25%
+200,000
New +$1.98M
TWST icon
111
Twist Bioscience
TWST
$7.74B
$1.63M 0.24%
+36,000
New +$1.29M
DMTK
112
DELISTED
DermTech, Inc. Common Stock
DMTK
$1.57M 0.24%
119,049
+71,407
+150% +$930K
BYSI icon
113
BeyondSpring
BYSI
$32.5M
$1.51M 0.23%
+100,000
New +$1.53M
RCOR
114
DELISTED
Renovacor, Inc.
RCOR
$1.49M 0.22%
+150,000
New +$1.5M
FOUR icon
115
Shift4
FOUR
$3.23B
$1.42M 0.21%
+40,000
New +$1.46M
VICR icon
116
Vicor
VICR
$9.99B
$1.4M 0.21%
+19,500
New +$1.09M
REPL icon
117
Replimune Group
REPL
$1.13B
$1.39M 0.21%
+56,000
New +$990K
GLUU
118
DELISTED
Glu Mobile Inc.
GLUU
$1.39M 0.21%
+150,000
New +$1.28M
CDTX
119
DELISTED
Cidara Therapeutics
CDTX
$1.36M 0.2%
18,455
– –
KPLT icon
120
Katapult Holdings
KPLT
$31.7M
$1.35M 0.2%
5,438
– –
AVEO
121
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.29M 0.19%
+250,000
New +$1.58M
HECCU
122
DELISTED
Hudson Executive Investment Corp. Units
HECCU
$1.28M 0.19%
+125,000
New +$1.27M
AXLA
123
DELISTED
Axcella Health Inc. Common Stock
AXLA
$1.24M 0.19%
+9,000
New +$1.1M
MTEM
124
DELISTED
Molecular Templates, Inc.
MTEM
$1.24M 0.19%
6,000
-6,293
-51% -$1.46M
VIRT icon
125
Virtu Financial
VIRT
$5B
$1.18M 0.18%
+50,000
New +$1.17M
3 4
5
6 7

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Monashee Investment Management held 214 positions worth $669M, up 258% from $187M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Monashee Investment Management deployed $394M of net new capital in Q2 2020, opening 153 new positions and adding to 2 existing holdings. Its largest new stake was Nikola Corporation Common Stock: 33,333 shares worth $67.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 5.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Molecular Templates, Inc., an estimated $1.46M trimmed.

  • Monashee Investment Management's largest Q2 2020 buy was Nikola Corporation Common Stock: 33,333 shares worth $67.5M.
  • Monashee Investment Management added most to DermTech, Inc. Common Stock in Q2 2020, an estimated $930K increase.
  • Monashee Investment Management's biggest Q2 2020 reduction was Molecular Templates, Inc., cutting an estimated $1.46M.
  • Monashee Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2020, selling an estimated $127M.
  • Monashee Investment Management's ten largest holdings make up 32% of its $669M portfolio in Q2 2020.
  • Monashee Investment Management opened 153 new positions and closed 16 in Q2 2020.
  • Monashee Investment Management's portfolio value rose 258% quarter-over-quarter to $669M.

Based on Monashee Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.